Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Edgewise Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 4.7% stake in Edgewise Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 7% stake in Edgewise Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2023 |
SC 13G/A
| Flynn James E reports a 6.2% stake in Edgewise Therapeutics, Inc. |
| 02/09/2023 |
SC 13G/A
| FMR LLC reports a 13.6% stake in EDGEWISE THERAPEUTICS INC |
| 10/11/2022 |
SC 13G/A
| FMR LLC reports a 12.6% stake in EDGEWISE THERAPEUTICS INC |
| 08/15/2022 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in EDGEWISE THERAPEUTICS, INC. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 5.5% stake in Edgewise Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| Cormorant Global Healthcare Master Fund, LP reports a 7.2% stake in Edgewise Therapeutics, Inc. |
| 01/13/2022 |
SC 13G/A
| CITADEL ADVISORS LLC reports a 5% stake in Edgewise Therapeutics, Inc. |
|
|